SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is trending following unconfirmed market buzz regarding potential M&A activity, leading to heightened trading volume and retail investor speculation. The community is actively debating the company's valuation, the credibility of buyout rumors, and the underlying strength of its commercial HAE franchise.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund (VCX) is seeing intense volatility and massive retail interest following its recent market debut, with the community closely tracking its exposure to high-profile private AI and tech companies like Anthropic, SpaceX, and OpenAI. Traders are actively debating the sustainability of the stock's significant premium to its Net Asset Value, while many early investors are discussing the implications of the 6-month lock-up period on the tradable float.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE has emerged as a trending meme coin, triggering polarized community debate between retail investors chasing rapid momentum and skeptics warning of a potential pump-and-dump scheme. While some traders tout its chart structure and low entry point as evidence of growth potential, critics highlight concentrated ownership among top holders and the lack of fundamental utility as major red flags.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is facing intense downward pressure as geopolitical volatility in the Middle East triggers massive flight disruptions and a sharp spike in jet fuel costs. The community is actively debating the stock's long-term viability, with many traders closely monitoring support levels while others speculate on the potential for a rapid recovery if the regional conflict de-escalates.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing intense community engagement driven by debates over its long-term commodity status and speculative supply-cut rumors. While some traders view current price levels as a high-conviction accumulation zone, others remain deeply skeptical, leading to a polarized environment between long-term holders and those calling for broader market caution.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as investors monitor the early commercial rollout of Yartemlea following recent FDA approval, with community discussions heavily focused on patient population penetration and revenue ramp-up potential. The stock remains a focal point for debate over institutional short positioning versus long-term value, as stakeholders look toward upcoming earnings and international regulatory progress for catalysts.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide (WRD) is trending following multiple operational updates, including the rollout of fully driverless commercial robotaxi services in the Middle East through an Uber partnership and successful autonomous driving competitions in China. While investors are actively debating the company's valuation gap compared to sector peers and its long-term scaling strategy, sentiment is heavily influenced by institutional accumulation, including increased holdings by ARK Invest, contrasted against concerns regarding the CEO's limited communication and the stock's recent volatility.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant downward pressure and intense community debate as investors navigate a post-earnings sell-off that has disconnected the stock's price from its strong financial performance. While some long-term holders argue this is a manipulation-driven opportunity to accumulate at a discount, others are increasingly vocal about their frustration with management and speculative concerns regarding a potential low-cost acquisition by PepsiCo.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors weigh an upcoming earnings report against significant growth projections, with community discussion intensely focused on whether the company's backlog and revenue outlook will trigger a major breakout. Traders are sharply divided between bulls expecting a short squeeze based on strong forward-looking guidance and bears skeptical of current valuation and federal contract timing.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is under intense investor scrutiny as it navigates significant cash runway concerns ahead of critical Phase 3 SENTRY trial results for myelofibrosis. While some investors are betting on a recovery through technical setups and institutional accumulation, the community remains deeply divided, frequently debating leadership competency, potential dilution, and the existential need for positive clinical data to avoid insolvency.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JPMorgan Chase & Co. Increases Stock Position in Synaptics Incorporated $SYNA

JPMorgan Chase & Co. raised its stake in shares of Synaptics Incorporated (NASDAQ:SYNA - Free Report) by 51.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 544,973 shares of the software maker's stock...

Synaptics (NASDAQ:SYNA) Insider Lisa Bodensteiner Sells 334 Shares

Synaptics Incorporated (NASDAQ:SYNA - Get Free Report) insider Lisa Bodensteiner sold 334 shares of the firm's stock in a transaction dated Wednesday, March 18th. The stock was sold at an average...

Insider Selling: Synaptics (NASDAQ:SYNA) Insider Sells 334 Shares of Stock

Synaptics Incorporated (NASDAQ:SYNA - Get Free Report) insider Lisa Bodensteiner sold 334 shares of the company's stock in a transaction dated Wednesday, March 18th. The shares were sold at an...

Dean Capital Management Buys New Position in Synaptics Incorporated $SYNA

Dean Capital Management bought a new stake in Synaptics Incorporated (NASDAQ:SYNA - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional...

Synaptics (NASDAQ:SYNA) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen downgraded Synaptics from a "buy" rating to a "hold" rating in a report on Saturday...

Victory Capital Management Inc. Reduces Stake in Synaptics Incorporated $SYNA

Victory Capital Management Inc. cut its stake in Synaptics Incorporated (NASDAQ:SYNA - Free Report) by 2.1% in the third quarter, according to its most recent 13F filing with the Securities...

Trigran Investments Inc. Has $45.20 Million Holdings in Synaptics Incorporated $SYNA

Trigran Investments Inc. reduced its holdings in shares of Synaptics Incorporated (NASDAQ:SYNA - Free Report) by 24.7% during the 3rd quarter, according to the company in its most recent 13F filing...

Synaptics Incorporated (NASDAQ:SYNA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Synaptics Incorporated (NASDAQ:SYNA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the fourteen ratings firms that are presently covering the firm...

Synaptics Incorporated $SYNA Shares Purchased by Legato Capital Management LLC

Legato Capital Management LLC increased its stake in shares of Synaptics Incorporated (NASDAQ:SYNA - Free Report) by 169.6% in the 3rd quarter, according to the company in its most recent filing with...

Vanguard Group Inc. Sells 22,734 Shares of Synaptics Incorporated $SYNA

Vanguard Group Inc. decreased its stake in shares of Synaptics Incorporated (NASDAQ:SYNA - Free Report) by 0.5% during the third quarter, according to its most recent filing with the Securities and...

Synaptics, Inc. engages in the development, marketing, and sale of human interface semiconductor solutions for electronic devices and products. It specializes in custom-designed human interface that enable people to interact with mobile computing, communications, entertainment, and other electronic devices. The company was founded by Federico Faggin and Carver A. Mead in March 1986 and is headquartered in San Jose, CA.

Current Price	$72.91
Prev Close	$71.03
Open	$73.59
Dividend Yield	0.00%
50-Day Moving Average	$82.32
Beta	2.02
Avg. Volume	826,847.20
PE Ratio	-45.79

52-Week High	$97.00
52-Week Low	$41.80
Market Capitalization	$2.82B
EPS (Annual)	-$1.22
Price to Book	2.04
Revenue Per Employee	$631,941.18

SYNA
Synaptics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SYNA News

SYNASynaptics Inc